세계의 감염 관리 시장 : 제품 및 서비스별, 최종사용자별, 지역별 - 예측(-2030년)
Infection Control Market by Product, Service, Disinfection, Gown, Mask, Endoscope Reprocessing, End User - Global Forecast to 2030
상품코드:1880367
리서치사:MarketsandMarkets
발행일:2025년 10월
페이지 정보:영문 691 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 감염 관리 시장 규모는 예측 기간 중에 CAGR 6.3%로 성장하여 2025년 573억 1,000만 달러에서 2030년에는 776억 7,000만 달러에 이를 것으로 예측됩니다.
조사 범위
조사 대상 기간
2024-2030년
기준 연도
2024년
예측 기간
2025-2030년
대상 단위
금액(10억 달러)
부문
제품 및 서비스별, 최종사용자별, 지역별
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가
세계적으로 의료 관련 감염(HAI)의 높은 확산, 수술 건수의 급증, 재처리 기술의 발전, 식품 살균 및 소독에 대한 관심 증가, 멸균 장비 기술의 향상으로 인해 시장은 높은 성장이 예상됩니다. 재처리 기기의 안전성과 화학 소독제 사용에 따른 영향에 대한 우려가 높아지면서 시장 성장을 억제할 수 있습니다.
최종 사용자별로 병원 및 클리닉, 의료기기 제조업체, 제약 회사, 생명 과학 산업, 기타 최종 사용자로 분류됩니다. 2024년 기준, 병원 및 클리닉 부문이 가장 큰 시장 점유율을 차지했습니다. 이러한 시설들은 24시간 운영되고, 다수의 환자를 관리하고, 복잡한 의료 시술을 시행하기 때문에 감염 전파 위험이 높아 감염 관리 시장에서 가장 큰 점유율을 차지하고 있습니다. 환자와 직원의 안전한 환경을 보장하기 위해 엄격한 위생 관리, 소독 및 멸균 프로토콜에 의존하고 있습니다. 또한, 규제 요건 준수와 고가의 감염 발생을 방지해야 할 필요성이 감염 예방에 대한 대규모 투자를 촉진하고 있으며, 병원 및 클리닉이 감염 관리 솔루션의 주요 최종 사용자로 부상하고 있습니다.
감염 관리 시장은 처리 방법별로 멸균 제품 및 서비스, 세척 및 소독 제품, 보호 장벽, 내시경 재처리 제품, 기타 감염 관리 제품으로 분류됩니다. 2024년 기준, 청소 및 소독 제품 부문이 가장 큰 시장 점유율을 차지했습니다. 세척 및 소독 제품은 표면, 의료기기 및 환경에서 유해한 병원균을 효과적으로 제거하고 감염 전파의 위험을 줄이기 위해 감염 관리에 매우 중요한 역할을 합니다. 이 제품들은 병원, 진료소, 연구소 및 기타 의료시설에서 위생 기준을 유지하고 환자와 의료진을 보호하는 데 필수적입니다. 빈번한 사용, 광범위한 적용 범위, 감염 사슬을 차단하는 본질적인 기능으로 인해 감염 관리 시장에서 가장 널리 사용되고 필수적인 부문이 되었습니다.
세계 감염 관리 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, 중동 및 아프리카, GCC 국가 등 6개 부문으로 나뉩니다. 아시아태평양은 빠르게 확장되는 의료 인프라, 증가하는 환자 수, 감염 예방에 대한 인식이 높아짐에 따라 감염 관리 시장에서 가장 빠르게 성장하는 지역입니다. 이 지역에서는 병원 건설, 의료 관광, 의료 투자가 눈에 띄게 증가하고 있으며, 이는 멸균, 소독, 위생 솔루션에 대한 수요를 견인하고 있습니다. 의료 관련 감염 발생 증가와 규제 기준의 강화로 병원 및 진료소에서는 보다 높은 수준의 감염 관리 기법을 도입하고 있습니다. 또한, 정부 주도의 정책, 제약 및 의료기기 제조 산업의 성장, 그리고 대규모 인구 기반이 이 지역의 견고한 시장 성장에 기여하고 있습니다.
북미는 잘 구축된 의료 시스템, 선진화된 기술 인프라, 혁신적인 감염 예방 솔루션의 높은 도입률로 감염 관리 시장을 선도하고 있습니다. 이 지역은 의료 R&D에 대한 막대한 투자, FDA와 같은 기관의 엄격한 규제 프레임워크, 주요 시장 기업의 강력한 존재감 등의 혜택을 누리고 있습니다. 의료비 증가, 높은 병원 내 감염 발생률, 환자 안전에 대한 관심은 살균-소독 제품 수요를 더욱 촉진하고 있습니다. 또한, 광범위한 교육 프로그램 및 인식 제고 캠페인으로 뒷받침되는 성숙한 시장 역학으로 인해 첨단 기술의 꾸준한 도입이 보장되어 북미는 전 세계 감염 관리 시장에서 선도적인 위치를 확고히 하고 있습니다.
세계의 감염 관리 시장에 대해 조사했으며, 제품 및 서비스별, 최종사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 프리미엄 인사이트
제5장 시장 개요
서론
시장 역학
성장 촉진요인
성장 억제요인
기회
과제
고객의 비즈니스에 영향을 미치는 동향/혼란
가격 분석
밸류체인 분석
공급망 분석
생태계 분석
투자 및 자금조달 시나리오
기술 분석
특허 분석
무역 분석
2025-2026년 주요 컨퍼런스 및 이벤트
사례 연구 분석
규제 분석
Porter의 Five Forces 분석
주요 이해관계자와 구입 기준
AI/생성형 AI가 감염 관리 시장에 미치는 영향
2025년 미국 관세가 감염 관리 시장에 미치는 영향
제6장 감염 관리 시장(제품 및 서비스별)
서론
멸균 제품 및 서비스
멸균 액세서리
멸균 소모품
청소 및 소독 제품
방호 배리어
내시경 재처리 제품
기타
제7장 감염 관리 시장(최종사용자별)
서론
병원 및 클리닉
의료기기 기업
제약회사
생명과학 산업
식품 업계
기타
제8장 감염 관리 시장(지역별)
서론
북미
북미의 거시경제 전망
미국
캐나다
유럽
유럽의 거시경제 전망
독일
영국
프랑스
이탈리아
스페인
스위스
기타
아시아태평양
아시아태평양의 거시경제 전망
일본
중국
인도
호주
한국
기타
라틴아메리카
라틴아메리카의 거시경제 전망
브라질
멕시코
기타
중동 및 아프리카
GCC 국가
제9장 경쟁 구도
개요
주요 시장 진출기업의 전략/강점, 2022년-2025년
매출 분석, 2022년-2024년
시장 점유율 분석, 2024년
기업 평가 매트릭스 : 주요 시장 진출기업, 2024년
기업 평가 매트릭스 : 스타트업 기업/중소기업, 2024년
기업 평가와 재무 지표
브랜드/제품 비교
경쟁 시나리오
제10장 기업 개요
주요 시장 진출기업
STERIS
RECKITT BENCKISER GROUP PLC
FORTIVE
SOTERA HEALTH
SOLVENTUM
GETINGE AB
ECOLAB, INC.
OLYMPUS CORPORATION
ENVISTA
PAUL HARTMANN AG
B. BRAUN SE
KIMBERLY-CLARK CORPORATION
CARDINAL HEALTH
PROCTER & GAMBLE
THE CLOROX COMPANY
STRYKER CORPORATION
HOYA CORPORATION
CONMED CORPORATION
FUJIFILM HOLDINGS CORPORATION
기타 기업
MIELE GROUP(JOINT VENTURE WITH METALL ZUG)
MMM GROUP
ANTONIO MATACHANA, S.A.
PAL INTERNATIONAL
SYSTEC GMBH & CO.KG
CONTEC, INC.
MEDALKAN
DR. SCHUMACHER GMBH
ULTRAWAVE
SCHULKE & MAYR GMBH
STERITEK INC.
제11장 부록
LSH
영문 목차
영문목차
The global infection control market is projected to reach USD 77.67 billion by 2030 from USD 57.31 billion in 2025, at a CAGR of 6.3% during the forecast period.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2025-2030
Units Considered
Value (USD billion)
Segments
Products & Services and End User
Regions covered
North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
The market is expected to experience high growth due to the high global prevalence of healthcare-associated infections (HAIs), a surge in surgeries, advancements in reprocessing technologies, a rising emphasis on the sterilization and disinfection of food, and improvements in sterilization equipment technology. Growing concerns about the safety of reprocessed instruments and the consequences associated with the use of chemical disinfectants will likely restrain market growth.
"The hospitals & clinics segment is expected to hold the largest position during the forecast period"
Based on end user, the market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, and other end users. In 2024, hospitals & clinics accounted for the largest share of the market. The hospitals and clinics segment holds the largest share of the infection control market as these facilities operate continuously, manage high patient volumes, and conduct complex medical procedures, all of which heighten the risk of infection transmission. To ensure safe environments for patients and staff, they rely on strict hygiene, disinfection, and sterilization protocols. Moreover, compliance with regulatory requirements and the need to prevent costly infection outbreaks drive significant investment in infection prevention, making hospitals and clinics the leading end users of infection control solutions.
"Cleaning & disinfection products segment accounts for the largest market share in the infection control market"
The infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products, based on treatment. The cleaning & disinfection products segment accounted for the largest share of the market in 2024. Cleaning & disinfection products play a crucial role in infection control as they effectively remove harmful pathogens from surfaces, medical equipment, and environments, thereby reducing the risk of infection transmission. These products are essential for maintaining hygiene standards in hospitals, clinics, laboratories, and other healthcare facilities, thereby protecting patients and healthcare personnel. Their frequent use, wide range of applications, and essential function in interrupting the infection chain make them the most extensively utilized and indispensable segment of the infection control market.
"Asia Pacific is expected to be the fastest-growing market for infection control during the forecast period, while North America leads in the market size"
The global infection control market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific is the fastest-growing region in the infection control market, driven by its rapidly expanding healthcare infrastructure, rising patient volumes, and increasing awareness of infection prevention. The region is experiencing significant growth in hospital construction, medical tourism, and healthcare investments, which drives the demand for sterilization, disinfection, and hygiene solutions. The increasing occurrence of healthcare-associated infections, along with the implementation of stricter regulatory standards, is driving hospitals and clinics to adopt more advanced infection control practices. Furthermore, government initiatives, the growth of pharmaceutical and medical device manufacturing, and a large population base are contributing to the robust market growth in the region.
North America leads the infection control market due to its well-established healthcare system, advanced technological infrastructure, and high adoption rates of innovative infection prevention solutions. The region benefits from significant investments in healthcare research and development, stringent regulatory frameworks enforced by agencies like the FDA, and a strong presence of leading market players. Rising healthcare expenditures, a high prevalence of hospital-acquired infections, and a focus on patient safety further bolster demand for sterilization and disinfection products. Additionally, the region's mature market dynamics, supported by extensive training programs and awareness campaigns, ensure a steady uptake of cutting-edge technologies, solidifying North America's dominant position in the global infection control market.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
By Designation: C Level: 28%, Director Level: 43%, and Others: 39%
By Region: North America: 35%, Europe: 20%, Asia Pacific: 30%, Latin America: 7%, Middle East & Africa: 5%, and GCC Countries: 3%
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the infection control market are STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US).
Research Coverage
This report examines the infection control market in terms of products & services, end-users, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms and smaller entrants to gauge the market's pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence.
This report provides insights into the following pointers:
Analysis of key Drivers (Rising prevalence of HAIs, increasing number of surgical procedures, Advancements in reprocessing technologies; Increasing emphasis on sterilization & disinfection of food; Advancements in sterilization equipment technology; Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals)
Restraints (Growing concerns about the safety of reprocessed instruments; Consequences associated with chemical disinfectant use; High cost of endoscopy reprocessing and limited reimbursements)
Opportunities (Increasing prevalence of medical devices and pharmaceutical companies in developing nations; Reintegration of ethylene oxide sterilization; Growing utilization of E-beam sterilization)
Challenges (Sterilization of advanced medical devices; Alternative methods for surface disinfection; Increasing adoption of single-use medical devices)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the infection control market
Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the infection control market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the infection control market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US)
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 List of key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key objectives of primary research
2.1.2.2 List of primary sources
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.1.2.5 Insights from industry experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Revenue estimation of key players
2.2.1.2 Study of annual reports and investor presentations
2.2.1.3 Primary interviews
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.4.1 RESEARCH-RELATED ASSUMPTIONS
2.4.2 PARAMETRIC ASSUMPTIONS
2.4.3 ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN INFECTION CONTROL MARKET
4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY END USER AND COUNTRY
4.3 INFECTION CONTROL MARKET, BY COUNTRY
4.4 INFECTION CONTROL MARKET, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of HAIs
5.2.1.2 Increasing number of surgical procedures
5.2.1.3 Advancements in reprocessing technologies
5.2.1.4 Increasing emphasis on sterilization & disinfection of food
5.2.1.5 Advancements in sterilization equipment technology
5.2.1.6 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals
5.2.2 RESTRAINTS
5.2.2.1 Growing concerns about safety of reprocessed instruments
5.2.2.2 Consequences associated with chemical disinfectant use
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursements
5.2.3 OPPORTUNITIES
5.2.3.1 Growing presence of medical device and pharmaceutical companies in developing nations
5.2.3.2 Reintegration of ethylene oxide sterilization
5.2.3.3 Growing utilization of E-beam sterilization
5.2.4 CHALLENGES
5.2.4.1 Sterilization of advanced medical devices
5.2.4.2 Alternative methods for surface disinfection
5.2.4.3 Increasing adoption of single-use medical devices
5.4.1 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY TYPE, 2023-2025
5.4.2 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY KEY PLAYER, 2023-2025
5.4.3 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY REGION, 2023-2025
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT & FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Heat sterilization
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Ultra-high-pressure sterilization
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Nitrogen dioxide (NO2)
5.10 PATENT ANALYSIS
5.10.1 LIST OF KEY PATENTS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 841920
5.11.2 EXPORT DATA FOR HS CODE 841920
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1: DILUTION DYSFUNCTION - EVALUATION OF AUTOMATED DISINFECTANT DISPENSER SYSTEMS IN 10 HOSPITALS
5.13.2 CASE STUDY 2: IMPLEMENTATION OF A NOVEL COLOR ADDITIVE FOR BLEACH DISINFECTANT WIPES ENHANCES CLEANING PERFORMANCE IN AN ACADEMIC MEDICAL CENTER
5.13.3 CASE STUDY 3: THE IMPACT OF ENHANCED CLEANING ON BACTERIAL CONTAMINATION OF HOSPITAL ENVIRONMENTAL SURFACES - A CLINICAL TRIAL IN CRITICAL CARE UNITS, EGYPT
5.14 REGULATORY ANALYSIS
5.14.1 REGULATORY LANDSCAPE
5.14.1.1 North America
5.14.1.1.1 US
5.14.1.1.2 Canada
5.14.1.2 Europe
5.14.1.3 Asia Pacific
5.14.1.3.1 Japan
5.14.1.3.2 China
5.14.1.3.3 Australia
5.14.1.4 Latin America
5.14.1.4.1 Brazil
5.14.1.4.2 Mexico
5.14.1.5 Middle East
5.14.1.6 Africa
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15 PORTER'S FIVE FORCES ANALYSIS
5.15.1 BARGAINING POWER OF SUPPLIERS
5.15.2 BARGAINING POWER OF BUYERS
5.15.3 THREAT OF NEW ENTRANTS
5.15.4 THREAT OF SUBSTITUTES
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 KEY BUYING CRITERIA
5.17 IMPACT OF AI/GEN AI ON INFECTION CONTROL MARKET
5.17.1 INTRODUCTION
5.17.2 POTENTIAL OF AI
5.17.3 IMPACT OF AI
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF AI
5.18 IMPACT OF 2025 US TARIFFS ON INFECTION CONTROL MARKET
5.18.1 INTRODUCTION
5.18.2 KEY TARIFF RATES
5.18.3 PRICE IMPACT ANALYSIS
5.18.4 IMPACT ON COUNTRY/REGION
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia Pacific
5.18.5 IMPACT ON END-USE INDUSTRIES
5.18.5.1 Hospitals & clinics
5.18.5.2 Medical device companies
5.18.5.3 Pharmaceutical & life science industry
5.18.5.4 Food industry
6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 STERILIZATION PRODUCTS & SERVICES
6.2.1 STERILIZATION EQUIPMENT
6.2.1.1 Heat sterilization equipment
6.2.1.1.1 Moist heat sterilizers
6.2.1.1.1.1 Versatility across material testing to fuel market growth
6.2.1.1.2 Dry heat sterilizers
6.2.1.1.2.1 Increasing demand for heat-sensitive instruments to boost demand
6.2.1.2 Low-temperature sterilization equipment
6.2.1.2.1 Hydrogen peroxide sterilizers
6.2.1.2.1.1 Effective application across broad industries to fuel market
6.2.1.2.2 Ethylene oxide (EtO) sterilizers
6.2.1.2.2.1 High penetration capabilities to fuel uptake
6.2.1.2.3 Formaldehyde sterilizers
6.2.1.2.3.1 Potent antimicrobial properties to aid adoption
6.2.1.2.4 Other low-temperature sterilization equipment
6.2.1.3 Radiation sterilizers
6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market
6.2.2 CONTRACT STERILIZATION SERVICES
6.2.2.1 EtO sterilization services
6.2.2.1.1 Expanding applications across medical device sterilization and life science industry to fuel market
6.2.2.2 Gamma sterilization services
6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake
6.2.2.3 E-beam sterilization services
6.2.2.3.1 Rapid processing and precise control to boost market
6.2.2.4 Steam sterilization services
6.2.2.4.1 Standard method with optimal efficiency to drive market
6.2.2.5 Other contract sterilization services
6.3 STERILIZATION ACCESSORIES
6.3.1 STERILIZATION INDICATORS
6.3.1.1 Chemical indicators
6.3.1.1.1 Low cost of chemical indicators to aid adoption
6.3.1.2 Biological indicators
6.3.1.2.1 Efficacy of biological indicators to drive demand
6.3.1.3 Sterilization pouches
6.3.1.3.1 Sterility maintenance with time duration to aid adoption
6.3.1.4 Sterilization lubricants
6.3.1.4.1 Prevention of equipment damage to support market growth
6.3.2 OTHER STERILIZATION ACCESSORIES
6.4 STERILIZATION CONSUMABLES
6.4.1 INCREASING DEMAND FOR STERILANTS IN FOOD & MEDICAL DEVICE INDUSTRIES TO SUPPORT MARKET GROWTH
6.5 CLEANING & DISINFECTION PRODUCTS
6.5.1 DISINFECTANTS
6.5.1.1 Disinfectants, by product type
6.5.1.1.1 Hand disinfectants
6.5.1.1.1.1 Rising awareness about health & hygiene to boost market
6.5.1.1.2 Surface disinfectants
6.5.1.1.2.1 Increasing prevalence of HAIs to fuel market
6.5.1.1.3 Skin disinfectants
6.5.1.1.3.1 Increasing incidence of infectious diseases to fuel market
6.5.1.1.4 Instrument disinfectants
6.5.1.1.4.1 Growing number of surgical procedures to boost demand
6.5.1.2 Disinfectants, by formulation
6.5.1.2.1 Disinfectant wipes
6.5.1.2.1.1 Easy accessibility to support market growth
6.5.1.2.2 Liquid disinfectants
6.5.1.2.2.1 Effective utilization and high affordability to propel market
6.5.1.2.3 Disinfectant sprays
6.5.1.2.3.1 Increasing usage of antimicrobial control measures to fuel demand
6.5.1.3 Disinfectants, by EPA classification
6.5.1.3.1 Low-level disinfectants
6.5.1.3.1.1 Effective elimination of vegetative bacteria and most viruses to boost demand
6.5.1.3.2 Intermediate-level disinfectants
6.5.1.3.2.1 Applications across dentistry and environmental monitoring to boost demand
6.5.1.3.3 High-level disinfectants
6.5.1.3.3.1 Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake
6.5.2 CLEANING & DISINFECTION EQUIPMENT
6.5.2.1 Washer disinfectors
6.5.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market
6.5.2.2 Flusher disinfectors
6.5.2.2.1 Innovative product launches to boost demand
6.5.2.3 UV-ray disinfectors
6.5.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market
6.5.2.4 Ultrasonic cleaners
6.5.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption
6.5.2.5 Other cleaning & disinfection equipment
6.5.3 LUBRICANTS & CLEANING SOLUTIONS
6.5.3.1 Utilization for disinfection of reprocessing instruments to drive market
6.5.4 DISINFECTION & CLEANING ACCESSORIES
6.5.4.1 Stringent regulatory standards to support market growth
6.6 PROTECTIVE BARRIERS
6.6.1 MEDICAL NONWOVENS
6.6.1.1 Face masks
6.6.1.1.1 Increasing prevalence of respiratory diseases to drive market
6.6.1.2 Surgical gowns
6.6.1.2.1 Growing awareness about infection control to fuel market
6.6.1.3 Surgical drapes
6.6.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake
6.6.2 COVERS & CLOSURES
6.6.2.1 Growing focus on food safety to fuel demand
6.6.3 GOGGLES
6.6.3.1 Increasing use of protective gear in research laboratories to support market growth
6.6.4 GLOVES
6.6.4.1 Growing concerns related to personnel safety to fuel uptake
6.7 ENDOSCOPE REPROCESSING PRODUCTS
6.7.1 ENDOSCOPE REPROCESSING CONSUMABLES
6.7.1.1 Rising number of endoscope procedures to fuel uptake
6.7.2 ENDOSCOPE REPROCESSING EQUIPMENT
6.7.2.1 Automated endoscope reprocessors
6.7.2.1.1 Growing impact of automated endoscope reprocessors on healthcare expansion to accelerate growth
6.7.2.2 Endoscope drying, storage, and transport systems
6.7.2.2.1 Need for patient safety and efficient reprocessing workflow to accelerate growth
6.7.3 ENDOSCOPE TRACKING SOLUTIONS
6.7.3.1 Improved traceability and supervision to foster growth
6.8 OTHER INFECTION CONTROL PRODUCTS
7 INFECTION CONTROL MARKET, BY END USER
7.1 INTRODUCTION
7.2 HOSPITALS & CLINICS
7.2.1 STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET
7.3 MEDICAL DEVICE COMPANIES
7.3.1 RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET
7.4 PHARMACEUTICAL COMPANIES
7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET
7.5 LIFE SCIENCE INDUSTRY
7.5.1 INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET
7.6 FOOD INDUSTRY
7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH
7.7 OTHER END USERS
8 INFECTION CONTROL MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
8.2.2 US
8.2.2.1 Rising prevalence of healthcare-associated infections (HAIs) to drive market
8.2.3 CANADA
8.2.3.1 Rising geriatric population to support market growth
8.3 EUROPE
8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
8.3.2 GERMANY
8.3.2.1 Growing adoption of hospital disinfection & surveillance systems to drive market
8.3.3 UK
8.3.3.1 High prevalence of HAIs to drive market
8.3.4 FRANCE
8.3.4.1 Stringent regulatory guidelines for infection control product commercialization to fuel uptake
8.3.5 ITALY
8.3.5.1 Increasing establishment of long-term care facilities to boost demand
8.3.6 SPAIN
8.3.6.1 Increasing prevalence of infectious diseases to fuel market
8.3.7 SWITZERLAND
8.3.7.1 Heightened burden of CAUTI to drive market
8.3.8 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
8.4.2 JAPAN
8.4.2.1 Increasing geriatric population and healthcare expenditure to drive market
8.4.3 CHINA
8.4.3.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market
8.4.4 INDIA
8.4.4.1 Extensive patient population to boost growth
8.4.5 AUSTRALIA
8.4.5.1 Increasing demand for healthcare services to support market growth
8.4.6 SOUTH KOREA
8.4.6.1 Increasing government efforts to broaden healthcare coverage to drive market
8.4.7 REST OF ASIA PACIFIC
8.5 LATIN AMERICA
8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
8.5.2 BRAZIL
8.5.2.1 Established pharmaceutical and biotechnology industries to drive market
8.5.3 MEXICO
8.5.3.1 Increasing prevalence of chronic disorders to aid market growth
8.5.4 REST OF LATIN AMERICA
8.6 MIDDLE EAST & AFRICA
8.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
8.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
8.7 GCC COUNTRIES
8.7.1 HIGHER DISPOSABLE INCOMES TO DRIVE DEMAND FOR HEALTHCARE SERVICES
8.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
9.2.1 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INFECTION CONTROL MARKET
9.3 REVENUE ANALYSIS, 2022-2024
9.4 MARKET SHARE ANALYSIS, 2024
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
9.5.5.1 Company footprint
9.5.5.2 Region footprint
9.5.5.3 Product & service footprint
9.5.5.4 End-user footprint
9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
